Glenmark Pharma, AstraZeneca ink pact for Pulmicort Respules Ruchika Sharma14 Feb 2022 5:36 PM ISTBogota: Glenmark Pharmaceuticals, a global pharmaceutical company, today announced that its subsidiary Glenmark Pharmaceuticals Colombia S.A.S. and...
AstraZeneca sees $4B in COVID vaccine sales as revenue soars Ruchika Sharma12 Feb 2022 9:00 AM ISTNew Delhi: AstraZeneca recorded a big jump in revenue on Thursday as it begins to take a profit from its coronavirus vaccine for the first time. The...
AstraZeneca in soup over suspected medical insurance fraud Ruchika Sharma31 Jan 2022 1:54 PM ISTThe company has taken disciplinary action against those employees and has reported their violations to the authorities, the statement said.
Sinovac CoronaVac shot gets strong boost from Pfizer, AstraZeneca, JnJ COVID doses, claims study Ruchika Sharma26 Jan 2022 10:00 AM ISTNew Delhi: A third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels...
AstraZeneca ropes in Ram Mudaliar as India Lead of CDI Division Ruchika Sharma24 Jan 2022 3:11 PM ISTBengaluru: AstraZeneca India Private Limited, the services arm of AstraZeneca has recently announced the appointment of Ram Mudaliar as the India lead...
AstraZeneca, Scorpion Therapeutics ink pact for novel cancer treatments against 'undruggable' targets Ruchika Sharma16 Jan 2022 10:00 AM ISTNew Delhi: AstraZeneca has signed a collaboration agreement with Scorpion Therapeutics to discover, develop and commercialise precision medicines...
Covishield 3rd dose increases antibody response against Omicron: Study Roshni Dhar14 Jan 2022 5:38 PM ISTA third dose of AstraZeneca's Covid vaccine, named Covishield in India, increases antibody response to the new vaccine-evading Omicron variant,...
Health Bulletin 14/January/2022 Roshni Dhar14 Jan 2022 5:07 PM ISTHere are Top Health stories of the dayIndia's daily positivity rate at 14.78%, over 12.72 lakh active casesGujarat to provide 10 % reservation to...
Covishield 3rd dose increases antibody response against Omicron, says Study MD Bureau13 Jan 2022 3:52 PM ISTLondon: A third dose of AstraZeneca's Covid vaccine, named Covishield in India, increases antibody response to the new vaccine-evading Omicron...
AstraZeneca closes Eplontersen agreement with Ionis Medical Dialogues Bureau2 Jan 2022 10:00 AM ISTUK: AstraZeneca has announced that the company has closed a global development and commercialisation agreement with Ionis Pharmaceuticals, Inc. for...
AstraZeneca to study cancer drug Datopotamab deruxtecan in India Medical Dialogues Team27 Dec 2021 6:39 PM ISTNew Delhi: In a significant development, major drug-maker AstraZeneca has got the go ahead from the Subject Expert Committee (SEC) functional under...
Misquoted: Experts clarify on Lancet study claiming protection offered by Covishield declines after 3 months Ruchika Sharma25 Dec 2021 3:40 PM ISTNew Delhi: The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca Covid-19 vaccine Covishield declines after...
